Chagas disease treatment, Lampit, receives FDA approval for use in children
by Press Release from Outbreak News Today on (#56NTE)
Bayer announced today that the United States Food and Drug Administration (FDA) has approved Lampit(R) (nifurtimox) for use in pediatric patients (from birth to less than 18 years of age and weighing at least 2.5 kg) for the treatment of Chagas disease (American Trypanosomiasis) caused by Trypanosoma cruzi (T. cruzi). Lampit, an antiprotozoal medication will be available [...]
The post Chagas disease treatment, Lampit, receives FDA approval for use in children appeared first on Outbreak News Today.